Announcements Trials
Browse Landscape

Phase

Phase 2 49Phase 3 32Phase 1 13Phase 1/2 8Phase 2/3 4Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 21Unknown 12Not yet recruiting 7Terminated 6Withdrawn 5Recruiting 4Active not recruiting 4

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Head & Neck 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Epstein-Barr Virus Infections 1Colonic Neoplasms 1

Interventions

Cisplatin 13Paclitaxel 11Cyclophosphamide 11Doxorubicin 10Magnetic Resonance Spectroscopy 9Gemcitabine 9Prednisone 8Docetaxel 8Specimen Handling 7Oxaliplatin 7Carboplatin 7Vincristine 6Etoposide 6Capecitabine 6pembrolizumab 5Rituximab 5Radiotherapy 5Leucovorin 5Cytarabine 5Bevacizumab 5atezolizumab 4Trastuzumab 4Platinum 4Nivolumab 4Fluorouracil 4Dexamethasone 4Biopsy 41,2-diaminocyclohexaneplatinum II citrate 4Watchful Waiting 3Taxes 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Active not recruiting × Fluorouracil × Clear all
NCT02135042 2026-05-07

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

NRG Oncology

Phase 2/3 Active not recruiting
685 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT04068103 2025-05-07

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

NRG Oncology

Phase 2/3 Active not recruiting
635 enrolled 9 charts
Gastrointestinal

Colonic Neoplasms

NCT01924819 2025-03-04

TOPGEAR

Australasian Gastro-Intestinal Trials Group

Phase 2/3 Active not recruiting
574 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02919787 2024-11-20

Nordic Pancreatic Cancer Trial (NorPACT) - 1

Oslo University Hospital

Phase 2/3 Active not recruiting
140 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡